| Product NDC: | 0555-9019 |
| Proprietary Name: | Portia |
| Non Proprietary Name: | levonorgestrel and ethinyl estradiol |
| Active Ingredient(s): | .03; .15 mg/1; mg/1 & nbsp; levonorgestrel and ethinyl estradiol |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0555-9019 |
| Labeler Name: | Barr Laboratories Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075866 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20020627 |
| Package NDC: | 0555-9019-57 |
| Package Description: | 6 BLISTER PACK in 1 CARTON (0555-9019-57) > 21 TABLET, FILM COATED in 1 BLISTER PACK |
| NDC Code | 0555-9019-57 |
| Proprietary Name | Portia |
| Package Description | 6 BLISTER PACK in 1 CARTON (0555-9019-57) > 21 TABLET, FILM COATED in 1 BLISTER PACK |
| Product NDC | 0555-9019 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | levonorgestrel and ethinyl estradiol |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20020627 |
| Marketing Category Name | ANDA |
| Labeler Name | Barr Laboratories Inc. |
| Substance Name | ETHINYL ESTRADIOL; LEVONORGESTREL |
| Strength Number | .03; .15 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Inhibit Ovum Fertilization [PE],Progesterone Congeners [Chemical/Ingredient],Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Progestin-containing Intrauterine Device [EPC],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |